| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,149,204 |
1,815,709 |
$233.87M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
165,456 |
131,113 |
$30.49M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
184,477 |
163,809 |
$27.63M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
158,585 |
146,739 |
$20.56M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
47,683 |
37,157 |
$15.22M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
62,120 |
57,687 |
$7.38M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
58,861 |
51,766 |
$6.81M |
| J9271 |
Injection, pembrolizumab, 1 mg |
1,014 |
589 |
$6.77M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
80,475 |
38,505 |
$6.70M |
| 90791 |
Psychiatric diagnostic evaluation |
26,831 |
24,981 |
$6.07M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28,258 |
26,633 |
$5.97M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
51,529 |
47,683 |
$5.94M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
72,506 |
69,135 |
$5.93M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
423,829 |
336,203 |
$4.28M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13,572 |
11,034 |
$4.21M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
5,299 |
5,087 |
$4.12M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
36,433 |
32,743 |
$4.11M |
| 90834 |
Psychotherapy, 45 minutes with patient |
30,573 |
25,744 |
$4.09M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
11,665 |
10,700 |
$3.80M |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
30,874 |
26,435 |
$3.72M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25,330 |
17,537 |
$3.53M |
| 70450 |
Computed tomography, head or brain; without contrast material |
15,154 |
12,320 |
$3.52M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
18,870 |
14,486 |
$3.40M |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
22,250 |
4,434 |
$3.20M |
| 20610 |
|
17,754 |
13,724 |
$2.85M |
| G0378 |
Hospital observation service, per hour |
39,164 |
14,453 |
$2.64M |
| 90832 |
Psychotherapy, 30 minutes with patient |
23,515 |
18,641 |
$2.51M |
| 92551 |
|
28,447 |
25,893 |
$2.40M |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
19,809 |
16,517 |
$2.31M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,509 |
16,784 |
$2.23M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
19,596 |
17,166 |
$2.18M |
| 90837 |
Psychotherapy, 53 minutes with patient |
15,888 |
11,283 |
$2.13M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
7,820 |
4,878 |
$2.12M |
| 90677 |
|
17,049 |
14,141 |
$1.96M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
13,386 |
12,336 |
$1.95M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,796 |
3,254 |
$1.90M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
80,923 |
54,133 |
$1.88M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
14,663 |
7,354 |
$1.80M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,979 |
11,893 |
$1.69M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,238 |
10,947 |
$1.65M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
8,672 |
7,908 |
$1.62M |
| H2019 |
Therapeutic behavioral services, per 15 minutes |
20,764 |
11,132 |
$1.57M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,291 |
10,037 |
$1.46M |
| 76801 |
|
10,818 |
9,239 |
$1.39M |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
5,485 |
5,101 |
$1.37M |
| D7140 |
Extraction, erupted tooth or exposed root |
1,395 |
1,067 |
$1.37M |
| 95811 |
|
2,142 |
1,996 |
$1.35M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
146,084 |
123,541 |
$1.35M |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
1,952 |
1,616 |
$1.31M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
14,806 |
8,642 |
$1.24M |
| 77386 |
|
3,751 |
282 |
$1.24M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,969 |
1,638 |
$1.23M |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
986 |
757 |
$1.23M |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
17,539 |
15,252 |
$1.22M |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,249 |
4,973 |
$1.19M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
1,041 |
833 |
$1.17M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
10,349 |
6,433 |
$1.17M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,341 |
2,001 |
$1.15M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
8,031 |
5,817 |
$1.13M |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
17,412 |
8,912 |
$1.10M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
11,746 |
6,077 |
$1.10M |
| 95886 |
|
3,836 |
3,608 |
$1.09M |
| 90686 |
|
95,830 |
81,095 |
$1.08M |
| 59025 |
Fetal non-stress test |
6,073 |
4,611 |
$1.06M |
| 80076 |
|
172,945 |
141,920 |
$1.05M |
| 97803 |
|
10,197 |
8,982 |
$1.04M |
| 80061 |
Lipid panel |
114,878 |
102,716 |
$1.01M |
| 95813 |
|
1,215 |
1,104 |
$997K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,067 |
2,530 |
$977K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
7,775 |
7,361 |
$957K |
| 11056 |
|
6,385 |
6,006 |
$947K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
8,502 |
7,585 |
$931K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
13,412 |
12,248 |
$882K |
| 52000 |
|
1,199 |
1,097 |
$879K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
17,159 |
15,803 |
$868K |
| 11102 |
|
1,982 |
1,738 |
$861K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
15,418 |
8,013 |
$832K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,473 |
1,956 |
$784K |
| 64483 |
|
1,431 |
1,268 |
$780K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
138,400 |
123,540 |
$778K |
| 90651 |
|
19,992 |
17,737 |
$773K |
| 36415 |
Collection of venous blood by venipuncture |
643,021 |
534,382 |
$755K |
| 96160 |
|
5,546 |
4,545 |
$749K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
146,496 |
123,908 |
$742K |
| 31575 |
|
2,970 |
2,776 |
$731K |
| 36000 |
|
8,965 |
6,991 |
$722K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
35,355 |
30,970 |
$670K |
| 70498 |
|
2,108 |
1,636 |
$669K |
| G0451 |
Development testing, with interpretation and report, per standardized instrument form |
11,701 |
10,536 |
$661K |
| 90750 |
|
3,618 |
2,835 |
$645K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
5,769 |
5,278 |
$638K |
| 87631 |
|
5,417 |
5,043 |
$601K |
| 11721 |
|
21,424 |
20,163 |
$600K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
177,809 |
161,527 |
$599K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
910 |
783 |
$584K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
851 |
691 |
$574K |
| 64493 |
|
808 |
692 |
$569K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
47,005 |
40,996 |
$569K |
| 17110 |
|
2,898 |
2,557 |
$568K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,252 |
1,042 |
$567K |
| 84443 |
Thyroid stimulating hormone (TSH) |
74,921 |
64,776 |
$564K |
| 76642 |
|
4,784 |
3,770 |
$560K |
| 92557 |
|
7,785 |
7,221 |
$556K |
| 95806 |
|
1,052 |
980 |
$555K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
917 |
676 |
$551K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
104,956 |
90,644 |
$533K |
| 96127 |
|
4,811 |
4,232 |
$523K |
| 43235 |
|
1,034 |
847 |
$502K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,721 |
1,532 |
$497K |
| 96415 |
|
1,949 |
1,173 |
$494K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
400 |
298 |
$488K |
| 97162 |
|
8,765 |
7,317 |
$484K |
| 97802 |
|
4,657 |
4,148 |
$484K |
| 86850 |
|
23,276 |
18,381 |
$475K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
239,364 |
186,250 |
$467K |
| 77412 |
|
3,590 |
321 |
$463K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
775 |
522 |
$449K |
| 27447 |
|
197 |
119 |
$444K |
| 76813 |
|
5,975 |
5,463 |
$439K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,914 |
2,453 |
$432K |
| T1002 |
Rn services, up to 15 minutes |
5,964 |
5,054 |
$426K |
| 71046 |
Radiologic examination, chest; 2 views |
59,005 |
50,903 |
$419K |
| 76770 |
|
2,329 |
2,099 |
$417K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
1,215 |
739 |
$415K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,463 |
3,282 |
$411K |
| H0036 |
Community psychiatric supportive treatment, face-to-face, per 15 minutes |
9,586 |
5,427 |
$403K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,652 |
1,101 |
$388K |
| 70491 |
|
1,188 |
980 |
$383K |
| 85027 |
|
120,964 |
102,550 |
$380K |
| 71271 |
|
2,031 |
1,876 |
$380K |
| 93017 |
|
4,270 |
3,800 |
$379K |
| 11900 |
|
1,836 |
1,654 |
$370K |
| 92567 |
|
13,001 |
12,081 |
$369K |
| 95117 |
|
10,453 |
5,797 |
$366K |
| 83655 |
|
25,361 |
22,198 |
$365K |
| 27130 |
|
83 |
52 |
$362K |
| 91200 |
|
2,940 |
2,815 |
$358K |
| 77336 |
|
3,657 |
1,320 |
$354K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
12,022 |
6,417 |
$353K |
| 11104 |
|
798 |
660 |
$345K |
| 11055 |
|
2,427 |
2,242 |
$342K |
| 57454 |
|
1,069 |
913 |
$339K |
| 76821 |
|
5,657 |
2,938 |
$336K |
| 59430 |
|
3,282 |
2,941 |
$334K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
594 |
495 |
$334K |
| 76820 |
|
5,618 |
2,912 |
$332K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
414 |
355 |
$328K |
| 20611 |
|
956 |
825 |
$327K |
| 90620 |
|
8,603 |
7,093 |
$327K |
| 86900 |
|
27,106 |
18,647 |
$324K |
| J0475 |
Injection, baclofen, 10 mg |
460 |
388 |
$319K |
| 92134 |
|
8,452 |
7,742 |
$319K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
227 |
170 |
$318K |
| J9173 |
Injection, durvalumab, 10 mg |
125 |
37 |
$317K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
149,169 |
110,561 |
$316K |
| 82607 |
|
33,838 |
29,392 |
$309K |
| 90648 |
|
36,592 |
33,248 |
$308K |
| J0897 |
Injection, denosumab, 1 mg |
339 |
243 |
$308K |
| 97166 |
|
4,281 |
3,270 |
$306K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
4,149 |
3,831 |
$303K |
| 97116 |
|
7,489 |
3,462 |
$301K |
| 20550 |
|
1,691 |
1,389 |
$301K |
| 76536 |
|
2,503 |
2,323 |
$300K |
| 93320 |
|
1,800 |
1,602 |
$300K |
| J2357 |
Injection, omalizumab, 5 mg |
301 |
209 |
$299K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,785 |
1,624 |
$293K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,799 |
4,868 |
$292K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,867 |
1,161 |
$289K |
| 90670 |
|
35,373 |
32,250 |
$279K |
| 94060 |
|
7,463 |
6,944 |
$272K |
| 19083 |
|
317 |
253 |
$272K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
4,603 |
1,411 |
$271K |
| 93970 |
|
1,662 |
1,411 |
$270K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
29,410 |
23,467 |
$267K |
| 71250 |
|
2,533 |
2,240 |
$266K |
| 66982 |
|
360 |
260 |
$262K |
| 76830 |
Ultrasound, transvaginal |
5,918 |
5,337 |
$258K |
| 58661 |
|
103 |
70 |
$251K |
| 62323 |
|
570 |
483 |
$250K |
| 77290 |
|
481 |
368 |
$246K |
| 74183 |
|
956 |
865 |
$246K |
| 93923 |
|
2,389 |
2,278 |
$240K |
| 86701 |
|
42,788 |
35,668 |
$237K |
| 90715 |
|
17,430 |
14,361 |
$236K |
| 96112 |
|
754 |
672 |
$235K |
| 0001A |
|
5,834 |
5,762 |
$231K |
| 36430 |
|
1,129 |
690 |
$229K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
809 |
534 |
$228K |
| 86780 |
|
32,063 |
26,301 |
$228K |
| 84484 |
|
55,107 |
34,491 |
$228K |
| 94010 |
|
2,587 |
2,437 |
$227K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
112,090 |
83,028 |
$225K |
| 64415 |
|
569 |
392 |
$224K |
| 73560 |
|
9,773 |
6,595 |
$221K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
545 |
509 |
$218K |
| 64721 |
|
333 |
257 |
$218K |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
226 |
178 |
$217K |
| 93971 |
|
2,697 |
2,264 |
$215K |
| 11750 |
|
487 |
357 |
$214K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
847 |
770 |
$213K |
| 93325 |
|
2,308 |
2,041 |
$206K |
| C1776 |
Joint device (implantable) |
708 |
489 |
$205K |
| 12001 |
|
1,126 |
975 |
$204K |
| 97165 |
|
2,301 |
1,915 |
$204K |
| 90633 |
|
21,841 |
19,553 |
$202K |
| 93308 |
|
631 |
483 |
$199K |
| 11100 |
|
521 |
476 |
$199K |
| 82728 |
|
21,265 |
18,194 |
$195K |
| 97535 |
Self-care/home management training, each 15 minutes |
5,489 |
3,649 |
$195K |
| 58558 |
|
147 |
105 |
$194K |
| 92523 |
|
2,295 |
1,882 |
$191K |
| 87536 |
|
8,739 |
7,561 |
$190K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
973 |
842 |
$189K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,333 |
2,653 |
$189K |
| 0002A |
|
4,639 |
4,605 |
$188K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
467 |
332 |
$188K |
| 72141 |
|
1,484 |
1,336 |
$185K |
| 87390 |
|
42,558 |
35,622 |
$183K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
17,152 |
15,802 |
$180K |
| 86803 |
|
24,193 |
20,067 |
$177K |
| 93975 |
|
1,228 |
1,017 |
$176K |
| 62321 |
|
415 |
344 |
$176K |
| 94729 |
|
6,671 |
6,220 |
$169K |
| 88142 |
|
18,737 |
16,574 |
$169K |
| 94618 |
|
1,872 |
1,712 |
$168K |
| 73630 |
|
10,556 |
8,268 |
$164K |
| 86702 |
|
42,811 |
35,668 |
$164K |
| 85610 |
|
49,247 |
37,959 |
$161K |
| 84439 |
|
12,772 |
11,099 |
$161K |
| 92083 |
|
4,415 |
4,143 |
$160K |
| 72197 |
|
509 |
461 |
$156K |
| 73610 |
|
8,823 |
7,170 |
$154K |
| 76641 |
|
1,778 |
865 |
$154K |
| 99406 |
|
6,646 |
5,939 |
$154K |
| 70486 |
|
2,679 |
2,197 |
$154K |
| 10005 |
|
369 |
325 |
$153K |
| 94726 |
|
4,791 |
4,460 |
$152K |
| 92133 |
|
5,277 |
4,915 |
$151K |
| 96910 |
|
3,059 |
537 |
$150K |
| 96367 |
|
2,310 |
1,378 |
$148K |
| 90723 |
|
30,431 |
27,658 |
$146K |
| 20526 |
|
727 |
605 |
$146K |
| 97161 |
|
2,597 |
2,219 |
$145K |
| 82274 |
|
5,623 |
5,169 |
$144K |
| 87522 |
Neg quan hep c or qual rna |
5,080 |
4,584 |
$143K |
| 87902 |
|
1,059 |
932 |
$140K |
| 99385 |
|
1,171 |
982 |
$140K |
| 0124A |
|
4,537 |
3,003 |
$139K |
| 10060 |
|
716 |
609 |
$138K |
| 20680 |
|
185 |
110 |
$138K |
| 73030 |
|
8,007 |
6,153 |
$138K |
| 74018 |
|
3,502 |
2,933 |
$134K |
| 12011 |
|
708 |
605 |
$133K |
| 99384 |
|
1,266 |
1,041 |
$133K |
| 11981 |
|
600 |
501 |
$132K |
| 11720 |
|
4,262 |
4,009 |
$130K |
| 90734 |
|
15,240 |
12,931 |
$128K |
| 92020 |
|
1,843 |
1,725 |
$127K |
| 74178 |
|
457 |
412 |
$127K |
| 99215 |
Prolong outpt/office vis |
777 |
714 |
$126K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
39,269 |
32,566 |
$126K |
| 58100 |
|
799 |
656 |
$125K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
9,796 |
8,542 |
$124K |
| 99383 |
|
1,210 |
1,033 |
$124K |
| 10061 |
|
722 |
587 |
$123K |
| 95885 |
|
398 |
354 |
$122K |
| 93270 |
|
1,440 |
1,272 |
$121K |
| 73221 |
|
516 |
465 |
$121K |
| 64566 |
|
239 |
129 |
$120K |
| 87210 |
|
110,381 |
52,709 |
$116K |
| 97163 |
|
1,762 |
1,555 |
$115K |
| 83540 |
|
21,878 |
18,765 |
$114K |
| 73130 |
|
7,905 |
6,044 |
$112K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
71,431 |
58,384 |
$112K |
| 11982 |
|
559 |
485 |
$111K |
| 12002 |
|
637 |
519 |
$110K |
| 88307 |
|
1,326 |
855 |
$109K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
6,302 |
5,032 |
$108K |
| 84466 |
|
21,762 |
18,650 |
$108K |
| 86140 |
|
17,442 |
14,716 |
$107K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
81,969 |
75,001 |
$107K |
| 76882 |
|
1,056 |
905 |
$105K |
| J9022 |
Injection, atezolizumab, 10 mg |
27 |
12 |
$104K |
| 81025 |
|
145,710 |
126,976 |
$103K |
| 86359 |
|
6,085 |
5,238 |
$102K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,134 |
1,642 |
$102K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,910 |
1,666 |
$102K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
32,898 |
20,619 |
$101K |
| 58300 |
|
933 |
739 |
$100K |
| 97129 |
|
2,019 |
721 |
$99K |
| 86481 |
|
3,916 |
3,408 |
$99K |
| 51700 |
|
582 |
433 |
$98K |
| J1750 |
Injection, iron dextran, 50 mg |
1,237 |
375 |
$98K |
| 31231 |
|
471 |
420 |
$97K |
| 11057 |
|
655 |
607 |
$97K |
| 76831 |
|
430 |
392 |
$96K |
| 94664 |
|
9,151 |
8,346 |
$96K |
| 29075 |
|
593 |
523 |
$94K |
| 82570 |
|
22,229 |
18,706 |
$94K |
| 51741 |
|
2,695 |
2,354 |
$92K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
7,377 |
6,094 |
$92K |
| H2017 |
Psychosocial rehabilitation services, per 15 minutes |
1,418 |
644 |
$91K |
| 73700 |
|
688 |
539 |
$91K |
| D7240 |
Removal of impacted tooth - completely bony |
121 |
91 |
$91K |
| 96130 |
|
433 |
396 |
$90K |
| 20600 |
|
516 |
419 |
$90K |
| 72100 |
|
3,100 |
2,714 |
$89K |
| 73110 |
|
5,704 |
4,418 |
$89K |
| 0003A |
|
2,483 |
2,328 |
$89K |
| 84403 |
|
6,936 |
5,941 |
$89K |
| 93296 |
|
4,019 |
3,776 |
$89K |
| 90636 |
|
2,229 |
2,082 |
$88K |
| 83735 |
|
59,658 |
41,105 |
$88K |
| 92587 |
|
995 |
916 |
$87K |
| 73502 |
|
4,633 |
3,952 |
$86K |
| 77080 |
|
1,315 |
1,184 |
$85K |
| 86355 |
|
3,240 |
2,926 |
$84K |
| 84153 |
|
10,709 |
9,441 |
$84K |
| 91320 |
|
3,238 |
2,757 |
$83K |
| 97597 |
|
726 |
568 |
$83K |
| 51798 |
|
3,765 |
3,358 |
$82K |
| 20605 |
|
512 |
436 |
$82K |
| 47562 |
|
38 |
27 |
$82K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
136 |
38 |
$81K |
| 72110 |
|
3,043 |
2,700 |
$81K |
| 90680 |
|
17,969 |
16,264 |
$81K |
| 72040 |
|
2,484 |
2,183 |
$80K |
| 95700 |
|
574 |
490 |
$80K |
| 87340 |
|
13,748 |
11,226 |
$79K |
| 95782 |
|
101 |
92 |
$79K |
| 77066 |
Tomosynthesis, mammo |
1,800 |
1,628 |
$78K |
| 81003 |
|
142,151 |
113,284 |
$78K |
| 99397 |
|
974 |
777 |
$77K |
| 74230 |
|
600 |
515 |
$77K |
| 76870 |
|
897 |
785 |
$77K |
| 77334 |
|
268 |
180 |
$76K |
| 51784 |
|
459 |
414 |
$76K |
| 84702 |
|
9,271 |
6,639 |
$76K |
| 17250 |
|
489 |
423 |
$76K |
| 64450 |
|
508 |
398 |
$76K |
| 81001 |
|
96,180 |
83,534 |
$75K |
| 72146 |
|
346 |
300 |
$74K |
| 80348 |
|
3,256 |
1,688 |
$74K |
| 86360 |
|
6,097 |
5,250 |
$73K |
| 25600 |
|
230 |
202 |
$73K |
| 0011A |
|
2,139 |
2,049 |
$72K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
145 |
76 |
$72K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
860 |
742 |
$72K |
| 26600 |
|
232 |
189 |
$72K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
66,794 |
54,524 |
$71K |
| G0127 |
Trimming of dystrophic nails, any number |
3,843 |
3,612 |
$71K |
| 83970 |
|
5,169 |
4,504 |
$70K |
| V5261 |
Hearing aid, digital, binaural, bte |
189 |
136 |
$69K |
| 76857 |
|
885 |
640 |
$69K |
| 86901 |
|
27,231 |
18,650 |
$69K |
| 99386 |
|
545 |
464 |
$68K |
| 93880 |
|
713 |
644 |
$68K |
| 95714 |
|
94 |
60 |
$67K |
| 72131 |
|
1,715 |
1,355 |
$67K |
| 88341 |
|
1,369 |
642 |
$66K |
| 58301 |
|
735 |
602 |
$65K |
| 77065 |
Tomosynthesis, mammo |
1,508 |
1,369 |
$65K |
| 0012A |
|
1,639 |
1,601 |
$64K |
| 77280 |
|
433 |
334 |
$64K |
| 70487 |
|
209 |
161 |
$64K |
| 72050 |
|
1,862 |
1,649 |
$64K |
| 92526 |
|
949 |
650 |
$64K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,715 |
1,896 |
$64K |
| 17311 |
|
130 |
110 |
$62K |
| 87081 |
|
29,822 |
26,688 |
$60K |
| 90716 |
|
4,392 |
3,746 |
$60K |
| Q3014 |
Telehealth originating site facility fee |
10,554 |
9,629 |
$60K |
| 36561 |
|
68 |
53 |
$59K |
| 97130 |
|
1,961 |
694 |
$59K |
| 99382 |
|
547 |
511 |
$58K |
| J0178 |
Injection, aflibercept, 1 mg |
59 |
41 |
$58K |
| 82948 |
|
38,552 |
21,600 |
$57K |
| 90656 |
|
6,145 |
6,115 |
$56K |
| 70496 |
|
1,882 |
1,468 |
$56K |
| 64615 |
|
208 |
179 |
$55K |
| V5160 |
Dispensing fee, binaural |
315 |
243 |
$54K |
| 99152 |
|
7,236 |
6,309 |
$53K |
| 72082 |
|
1,237 |
1,113 |
$53K |
| 86706 |
|
5,974 |
5,106 |
$53K |
| 93246 |
|
577 |
510 |
$53K |
| 73562 |
|
2,606 |
1,744 |
$53K |
| 96416 |
|
305 |
116 |
$51K |
| 82670 |
|
3,445 |
2,996 |
$51K |
| 81329 |
|
1,032 |
867 |
$50K |
| 71045 |
Radiologic examination, chest; single view |
9,452 |
7,584 |
$50K |
| 70480 |
|
315 |
274 |
$50K |
| 26720 |
|
165 |
130 |
$49K |
| 29085 |
|
364 |
325 |
$49K |
| 95708 |
|
71 |
63 |
$48K |
| H0006 |
Alcohol and/or drug services; case management |
1,521 |
708 |
$48K |
| J1756 |
Injection, iron sucrose, 1 mg |
873 |
386 |
$48K |
| 90480 |
|
3,423 |
3,096 |
$47K |
| 92579 |
|
828 |
762 |
$47K |
| 0071A |
|
1,661 |
1,167 |
$47K |
| 62370 |
|
624 |
504 |
$46K |
| 86580 |
|
2,133 |
1,788 |
$46K |
| 0004A |
|
1,466 |
1,378 |
$46K |
| 17000 |
|
399 |
365 |
$46K |
| 96132 |
|
208 |
186 |
$45K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
523 |
312 |
$45K |
| 95913 |
|
606 |
542 |
$45K |
| 27096 |
|
106 |
90 |
$44K |
| 83880 |
|
8,954 |
7,264 |
$44K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
3,277 |
2,980 |
$43K |
| 64418 |
|
182 |
153 |
$43K |
| Q9991 |
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
79 |
62 |
$43K |
| 77385 |
|
346 |
26 |
$43K |
| 86357 |
|
3,240 |
2,926 |
$43K |
| 97750 |
|
576 |
468 |
$43K |
| 97763 |
|
642 |
437 |
$42K |
| 99381 |
|
374 |
338 |
$42K |
| 74170 |
|
160 |
135 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
52,158 |
47,326 |
$40K |
| 82105 |
|
5,123 |
4,550 |
$40K |
| 82043 |
|
14,205 |
12,264 |
$40K |
| 90696 |
|
5,395 |
4,686 |
$39K |
| 86235 |
|
7,031 |
2,970 |
$39K |
| 64447 |
|
348 |
201 |
$39K |
| 93225 |
|
479 |
439 |
$39K |
| 95816 |
|
349 |
336 |
$39K |
| 93242 |
|
437 |
416 |
$39K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
40 |
27 |
$39K |
| 88360 |
|
462 |
226 |
$38K |
| 97760 |
|
616 |
488 |
$38K |
| 64643 |
|
100 |
83 |
$37K |
| 97032 |
|
620 |
357 |
$37K |
| 73080 |
|
3,081 |
2,408 |
$37K |
| 72128 |
|
1,210 |
946 |
$36K |
| 77300 |
|
114 |
72 |
$36K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,222 |
1,116 |
$36K |
| 86923 |
|
1,339 |
603 |
$36K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
11,501 |
10,134 |
$35K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
4,491 |
3,529 |
$35K |
| 73590 |
|
3,081 |
2,341 |
$35K |
| 86038 |
|
4,023 |
3,299 |
$35K |
| 74174 |
|
482 |
392 |
$34K |
| 92611 |
|
540 |
472 |
$34K |
| V5266 |
Battery for use in hearing device |
6,138 |
5,679 |
$34K |
| 58340 |
|
304 |
276 |
$34K |
| 90710 |
|
7,442 |
6,495 |
$34K |
| 90746 |
|
2,326 |
1,890 |
$33K |
| 97167 |
|
390 |
316 |
$33K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
67 |
48 |
$33K |
| S9472 |
Cardiac rehabilitation program, non-physician provider, per diem |
492 |
88 |
$33K |
| 58662 |
|
26 |
14 |
$33K |
| 86592 |
|
4,004 |
3,402 |
$32K |
| 0072A |
|
959 |
813 |
$32K |
| 95910 |
|
348 |
319 |
$32K |
| 90785 |
|
3,044 |
2,574 |
$31K |
| 64490 |
|
49 |
41 |
$31K |
| 73140 |
|
2,117 |
1,732 |
$31K |
| 11983 |
|
68 |
47 |
$31K |
| 96101 |
|
206 |
162 |
$30K |
| 81002 |
|
52,945 |
39,157 |
$30K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
38,410 |
30,363 |
$30K |
| 90714 |
|
1,689 |
1,331 |
$29K |
| 86704 |
|
3,264 |
2,797 |
$28K |
| 85652 |
|
15,166 |
12,989 |
$28K |
| 83718 |
|
11,083 |
9,462 |
$28K |
| 36589 |
|
45 |
43 |
$27K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
39,964 |
29,056 |
$27K |
| 96368 |
|
1,369 |
872 |
$27K |
| 82465 |
|
11,157 |
9,523 |
$26K |
| 11730 |
|
284 |
255 |
$26K |
| 77077 |
|
878 |
791 |
$25K |
| 85018 |
|
5,109 |
4,377 |
$25K |
| 73564 |
|
4,965 |
3,555 |
$25K |
| 78264 |
|
113 |
96 |
$25K |
| 90700 |
|
4,872 |
4,211 |
$24K |
| 86225 |
|
4,050 |
3,384 |
$24K |
| 83883 |
|
1,699 |
1,292 |
$24K |
| 90707 |
|
4,237 |
3,640 |
$24K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
1,223 |
818 |
$24K |
| 83020 |
|
3,411 |
2,305 |
$24K |
| 95912 |
|
270 |
249 |
$23K |
| 72070 |
|
886 |
730 |
$22K |
| 77301 |
|
20 |
14 |
$22K |
| J3145 |
Injection, testosterone undecanoate, 1 mg |
20 |
12 |
$22K |
| 83615 |
|
6,193 |
4,316 |
$21K |
| 92610 |
|
566 |
460 |
$21K |
| 94727 |
|
767 |
693 |
$21K |
| 95911 |
|
319 |
279 |
$21K |
| 94660 |
|
215 |
85 |
$21K |
| 90662 |
|
2,975 |
2,404 |
$21K |
| 87077 |
|
7,021 |
5,166 |
$21K |
| 96136 |
|
661 |
602 |
$21K |
| 26055 |
|
34 |
14 |
$20K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
870 |
702 |
$20K |
| 87186 |
|
9,621 |
7,202 |
$20K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
276 |
189 |
$20K |
| 82040 |
|
5,500 |
4,583 |
$19K |
| J2791 |
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
314 |
233 |
$19K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
18,580 |
17,361 |
$19K |
| 73552 |
|
1,861 |
1,413 |
$19K |
| 82565 |
|
3,039 |
2,376 |
$19K |
| 84460 |
|
7,684 |
6,597 |
$19K |
| 83721 |
|
6,394 |
5,710 |
$19K |
| 86870 |
|
566 |
292 |
$19K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
146 |
54 |
$19K |
| 84100 |
|
9,340 |
7,142 |
$19K |
| 86708 |
|
2,902 |
2,593 |
$19K |
| 73522 |
|
772 |
688 |
$18K |
| 77072 |
|
413 |
358 |
$18K |
| 86160 |
|
3,745 |
1,574 |
$18K |
| 82784 |
|
3,933 |
2,347 |
$18K |
| 0154A |
|
437 |
328 |
$18K |
| 93922 |
|
270 |
242 |
$18K |
| J7300 |
Intrauterine copper contraceptive (paragard) |
15 |
12 |
$18K |
| 86003 |
|
2,314 |
1,306 |
$18K |
| 55700 |
|
19 |
12 |
$18K |
| 0013A |
|
640 |
563 |
$18K |
| 83001 |
|
2,257 |
1,902 |
$18K |
| 28470 |
|
57 |
48 |
$18K |
| 64642 |
|
201 |
178 |
$17K |
| 84156 |
|
7,303 |
5,804 |
$17K |
| 29405 |
|
126 |
98 |
$17K |
| 73200 |
|
147 |
129 |
$17K |
| 84146 |
|
1,939 |
1,624 |
$17K |
| 82746 |
|
4,114 |
3,394 |
$17K |
| 86762 |
|
2,863 |
2,147 |
$16K |
| 90647 |
|
1,666 |
1,579 |
$16K |
| 38222 |
|
17 |
12 |
$16K |
| 72170 |
|
1,536 |
1,214 |
$16K |
| 83516 |
|
1,501 |
940 |
$16K |
| 27786 |
|
48 |
43 |
$16K |
| 82533 |
|
940 |
734 |
$16K |
| 80349 |
|
828 |
525 |
$15K |
| 92250 |
|
829 |
779 |
$15K |
| 97542 |
|
245 |
214 |
$15K |
| 96376 |
|
5,530 |
3,133 |
$15K |
| 87493 |
|
606 |
465 |
$15K |
| D7230 |
|
30 |
19 |
$15K |
| 84481 |
|
2,132 |
1,847 |
$15K |
| 96125 |
|
72 |
66 |
$15K |
| 69210 |
|
1,566 |
1,424 |
$15K |
| 87338 |
|
797 |
718 |
$15K |
| 84450 |
|
4,606 |
4,024 |
$14K |
| 77002 |
|
1,615 |
1,351 |
$14K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
153 |
113 |
$14K |
| 49083 |
|
32 |
12 |
$14K |
| 0111A |
|
527 |
305 |
$14K |
| 76514 |
|
627 |
581 |
$14K |
| 84550 |
|
4,765 |
3,539 |
$14K |
| 83690 |
|
25,058 |
20,541 |
$14K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
101 |
94 |
$14K |
| 83605 |
|
10,372 |
6,817 |
$14K |
| 0054A |
|
898 |
342 |
$14K |
| 73090 |
|
2,080 |
1,551 |
$14K |
| 0051A |
|
610 |
301 |
$13K |
| 97035 |
|
151 |
83 |
$13K |
| 84480 |
|
1,762 |
1,554 |
$13K |
| 82077 |
|
11,916 |
9,312 |
$13K |
| 0134A |
|
499 |
356 |
$13K |
| 64635 |
|
16 |
13 |
$13K |
| 96131 |
|
231 |
212 |
$13K |
| J9045 |
Injection, carboplatin, 50 mg |
844 |
419 |
$13K |
| 72156 |
|
75 |
64 |
$13K |
| 90632 |
|
1,099 |
1,018 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,289 |
1,972 |
$12K |
| 87088 |
|
6,217 |
5,181 |
$12K |
| 82951 |
|
515 |
473 |
$12K |
| 73620 |
|
558 |
393 |
$12K |
| 75635 |
|
44 |
38 |
$12K |
| 19081 |
|
13 |
13 |
$12K |
| 82950 |
|
3,278 |
2,815 |
$12K |
| 99153 |
Mod sedat endo service >5yrs |
1,689 |
1,375 |
$12K |
| 82550 |
|
4,992 |
3,546 |
$12K |
| 93350 |
|
785 |
681 |
$11K |
| 86735 |
|
877 |
755 |
$11K |
| G0008 |
Administration of influenza virus vaccine |
5,320 |
4,433 |
$11K |
| 36902 |
|
15 |
13 |
$11K |
| 80164 |
|
1,221 |
971 |
$11K |
| J3471 |
Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
226 |
123 |
$11K |
| 93978 |
|
89 |
79 |
$11K |
| 93926 |
|
138 |
121 |
$11K |
| 86431 |
|
1,752 |
1,492 |
$11K |
| 87070 |
|
4,266 |
3,272 |
$11K |
| D1120 |
Prophylaxis - child |
213 |
165 |
$11K |
| 84144 |
|
703 |
503 |
$11K |
| 97533 |
|
164 |
117 |
$11K |
| 96138 |
|
206 |
183 |
$10K |
| 73660 |
|
807 |
682 |
$10K |
| 84445 |
|
524 |
479 |
$10K |
| 11103 |
|
189 |
167 |
$10K |
| 51728 |
|
80 |
71 |
$10K |
| 87517 |
|
585 |
511 |
$10K |
| 80320 |
|
1,022 |
895 |
$10K |
| 80365 |
|
645 |
563 |
$10K |
| 72114 |
|
275 |
252 |
$10K |
| 99407 |
|
385 |
344 |
$10K |
| 87045 |
|
654 |
533 |
$10K |
| 87046 |
|
1,307 |
533 |
$10K |
| 85730 |
|
13,631 |
10,385 |
$10K |
| 90739 |
|
788 |
704 |
$10K |
| 92553 |
|
138 |
119 |
$10K |
| 84165 |
|
1,950 |
1,605 |
$10K |
| 87529 |
|
3,153 |
1,350 |
$10K |
| 90681 |
|
1,209 |
1,025 |
$9K |
| 76883 |
|
104 |
88 |
$9K |
| 73060 |
|
1,260 |
997 |
$9K |
| 86787 |
|
1,266 |
994 |
$9K |
| 26750 |
|
27 |
24 |
$9K |
| C1889 |
Implantable/insertable device, not otherwise classified |
6,669 |
5,693 |
$9K |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
56 |
39 |
$9K |
| 90685 |
|
1,069 |
992 |
$9K |
| 84630 |
|
955 |
832 |
$9K |
| 91010 |
|
41 |
40 |
$9K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,619 |
2,836 |
$9K |
| 86376 |
|
984 |
850 |
$9K |
| 82378 |
|
757 |
520 |
$9K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
6,788 |
5,255 |
$9K |
| 72190 |
|
325 |
267 |
$9K |
| 82947 |
|
3,037 |
2,535 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
68,774 |
53,213 |
$8K |
| 77333 |
|
78 |
60 |
$8K |
| 95012 |
|
772 |
690 |
$8K |
| 0052A |
|
239 |
193 |
$8K |
| 86765 |
|
876 |
755 |
$8K |
| 87427 |
|
1,211 |
489 |
$8K |
| J8501 |
Aprepitant, oral, 5 mg |
752 |
504 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
36,738 |
24,609 |
$8K |
| C9153 |
Injection, amisulpride, 1 mg |
67 |
49 |
$8K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
3,713 |
3,068 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
60,192 |
26,288 |
$8K |
| 12032 |
|
202 |
173 |
$8K |
| 83002 |
|
1,189 |
1,008 |
$8K |
| 12013 |
|
46 |
40 |
$8K |
| 87147 |
|
6,191 |
3,673 |
$8K |
| 73000 |
|
536 |
430 |
$8K |
| 82952 |
|
495 |
455 |
$8K |
| 83520 |
|
747 |
616 |
$7K |
| 0112A |
|
215 |
162 |
$7K |
| 85045 |
|
3,306 |
2,635 |
$7K |
| 29065 |
|
43 |
38 |
$7K |
| 92136 |
|
282 |
271 |
$7K |
| 82627 |
|
711 |
598 |
$7K |
| 82247 |
|
1,742 |
1,267 |
$7K |
| J0185 |
Injection, aprepitant, 1 mg |
72 |
26 |
$7K |
| 90678 |
|
769 |
658 |
$7K |
| 82525 |
|
749 |
637 |
$7K |
| 86304 |
|
600 |
452 |
$7K |
| 93299 |
|
296 |
269 |
$7K |
| 77338 |
|
20 |
14 |
$7K |
| 70360 |
|
317 |
279 |
$7K |
| 83986 |
|
839 |
514 |
$7K |
| 84270 |
|
888 |
764 |
$7K |
| D7210 |
Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth |
18 |
12 |
$7K |
| 36591 |
|
936 |
550 |
$6K |
| 86695 |
|
912 |
783 |
$6K |
| 94770 |
|
82 |
81 |
$6K |
| 93298 |
|
289 |
270 |
$6K |
| 84425 |
|
993 |
865 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
58,518 |
42,033 |
$6K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
94 |
51 |
$6K |
| 92582 |
|
153 |
135 |
$6K |
| 86334 |
|
875 |
696 |
$6K |
| 82677 |
|
748 |
622 |
$6K |
| 87486 |
|
1,209 |
1,005 |
$6K |
| 83993 |
|
344 |
300 |
$6K |
| 84681 |
|
833 |
690 |
$6K |
| 70250 |
|
108 |
95 |
$6K |
| 88304 |
|
2,818 |
2,029 |
$6K |
| 80177 |
|
1,214 |
926 |
$6K |
| 86593 |
|
828 |
691 |
$6K |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
960 |
507 |
$6K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
10,238 |
4,367 |
$6K |
| 51729 |
|
128 |
117 |
$6K |
| 86255 |
|
798 |
516 |
$6K |
| 86200 |
|
1,001 |
865 |
$6K |
| 83010 |
|
1,113 |
890 |
$5K |
| 74019 |
|
251 |
223 |
$5K |
| 87205 |
|
4,154 |
3,182 |
$5K |
| 92950 |
|
15 |
12 |
$5K |
| 0164A |
|
134 |
116 |
$5K |
| 87328 |
|
507 |
430 |
$5K |
| 86696 |
|
912 |
783 |
$5K |
| 72158 |
|
52 |
41 |
$5K |
| 82977 |
|
1,133 |
963 |
$5K |
| 71101 |
|
419 |
353 |
$5K |
| 86341 |
|
583 |
312 |
$5K |
| 87449 |
|
709 |
555 |
$5K |
| 85378 |
|
2,810 |
2,279 |
$5K |
| D0120 |
Periodic oral evaluation - established patient |
125 |
91 |
$5K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
85 |
42 |
$5K |
| 82172 |
|
597 |
514 |
$5K |
| 64454 |
|
23 |
14 |
$5K |
| 36592 |
|
4,740 |
3,837 |
$5K |
| 96402 |
|
1,107 |
846 |
$5K |
| 86709 |
|
543 |
463 |
$5K |
| 82785 |
|
828 |
720 |
$5K |
| 65855 |
|
46 |
40 |
$5K |
| 80178 |
|
378 |
304 |
$5K |
| 73650 |
|
382 |
300 |
$4K |
| 77073 |
|
252 |
237 |
$4K |
| 31579 |
|
13 |
13 |
$4K |
| 82310 |
|
642 |
479 |
$4K |
| 96133 |
|
201 |
180 |
$4K |
| Q0114 |
Fern test |
773 |
475 |
$4K |
| 88112 |
|
847 |
696 |
$4K |
| 84155 |
|
1,977 |
1,629 |
$4K |
| 87634 |
|
1,001 |
879 |
$4K |
| 90732 |
|
399 |
265 |
$4K |
| 87329 |
|
507 |
430 |
$4K |
| A7034 |
Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap |
81 |
78 |
$4K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
6,056 |
1,759 |
$4K |
| 72072 |
|
231 |
222 |
$4K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,348 |
542 |
$4K |
| 86364 |
|
419 |
390 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,449 |
4,253 |
$4K |
| 99457 |
|
40 |
40 |
$4K |
| 86800 |
|
364 |
322 |
$4K |
| 83013 |
|
79 |
44 |
$4K |
| 93925 |
|
54 |
49 |
$4K |
| 64445 |
|
14 |
13 |
$4K |
| 84132 |
|
1,984 |
1,448 |
$4K |
| 87040 |
|
2,479 |
1,049 |
$4K |
| A4648 |
Tissue marker, implantable, any type, each |
648 |
537 |
$3K |
| 83921 |
|
630 |
512 |
$3K |
| 86705 |
|
413 |
338 |
$3K |
| J3490 |
Unclassified drugs |
548 |
317 |
$3K |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
189 |
107 |
$3K |
| 00731 |
|
2,671 |
2,167 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
5,640 |
4,142 |
$3K |
| 90381 |
|
463 |
442 |
$3K |
| 93280 |
|
230 |
213 |
$3K |
| 82610 |
|
360 |
309 |
$3K |
| 00902 |
|
239 |
176 |
$3K |
| 82803 |
|
2,377 |
1,489 |
$3K |
| J0476 |
Injection, baclofen, 50 mcg for intrathecal trial |
53 |
36 |
$3K |
| 20553 |
|
30 |
25 |
$3K |
| 92285 |
|
40 |
38 |
$3K |
| 00840 |
|
1,049 |
744 |
$3K |
| 90380 |
|
416 |
384 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,676 |
1,919 |
$3K |
| 0031A |
|
82 |
78 |
$3K |
| 85660 |
|
948 |
608 |
$3K |
| 82010 |
|
1,786 |
1,191 |
$3K |
| 86336 |
|
777 |
643 |
$3K |
| 96113 |
|
304 |
275 |
$3K |
| 96417 |
|
1,651 |
824 |
$3K |
| 78306 |
|
12 |
12 |
$3K |
| 98926 |
|
58 |
54 |
$3K |
| 88342 |
|
2,722 |
2,002 |
$3K |
| J3489 |
Injection, zoledronic acid, 1 mg |
226 |
179 |
$3K |
| 87581 |
|
1,214 |
1,008 |
$3K |
| 86308 |
|
558 |
464 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
6,787 |
4,162 |
$3K |
| 69209 |
|
2,413 |
2,098 |
$3K |
| 90474 |
|
7,283 |
6,950 |
$3K |
| 82330 |
|
857 |
518 |
$3K |
| 72220 |
|
155 |
125 |
$3K |
| 76512 |
|
18 |
13 |
$3K |
| 99201 |
|
15 |
14 |
$3K |
| 94761 |
|
52,244 |
44,044 |
$3K |
| 87206 |
|
1,170 |
706 |
$3K |
| 90672 |
|
295 |
262 |
$3K |
| 29705 |
|
14 |
12 |
$3K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
26 |
26 |
$3K |
| 97804 |
|
20 |
13 |
$3K |
| 92550 |
|
118 |
111 |
$3K |
| 87563 |
|
951 |
856 |
$3K |
| J9171 |
Injection, docetaxel, 1 mg |
44 |
24 |
$3K |
| 01992 |
|
847 |
719 |
$2K |
| 81050 |
|
310 |
273 |
$2K |
| 87109 |
|
542 |
465 |
$2K |
| 84166 |
|
341 |
295 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
25,179 |
13,077 |
$2K |
| 90744 |
|
453 |
381 |
$2K |
| 72192 |
|
33 |
25 |
$2K |
| 29580 |
|
21 |
14 |
$2K |
| 86147 |
|
292 |
125 |
$2K |
| 90713 |
|
446 |
400 |
$2K |
| 17003 |
|
107 |
104 |
$2K |
| 83521 |
|
435 |
384 |
$2K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
29 |
26 |
$2K |
| J3372 |
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg |
1,064 |
528 |
$2K |
| 29515 |
|
803 |
669 |
$2K |
| 00940 |
|
95 |
68 |
$2K |
| J0703 |
Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg |
511 |
219 |
$2K |
| 20552 |
|
20 |
14 |
$2K |
| 00400 |
|
703 |
514 |
$2K |
| 96156 |
|
14 |
14 |
$2K |
| 96401 |
|
225 |
126 |
$2K |
| 86665 |
|
345 |
147 |
$2K |
| 97164 |
|
21 |
18 |
$2K |
| 96523 |
|
85 |
53 |
$2K |
| 00811 |
|
1,389 |
1,124 |
$2K |
| V5014 |
Repair/modification of a hearing aid |
57 |
55 |
$2K |
| 94760 |
|
41,581 |
36,488 |
$2K |
| 90698 |
|
247 |
199 |
$2K |
| 83525 |
|
122 |
106 |
$2K |
| 87015 |
|
334 |
214 |
$2K |
| J1953 |
Injection, levetiracetam, 10 mg |
198 |
105 |
$2K |
| 64494 |
|
971 |
660 |
$2K |
| 72120 |
|
61 |
53 |
$2K |
| 86301 |
|
167 |
122 |
$2K |
| 76937 |
|
403 |
281 |
$2K |
| 84432 |
|
75 |
65 |
$2K |
| 90688 |
|
162 |
155 |
$2K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,090 |
498 |
$2K |
| 80143 |
|
691 |
497 |
$2K |
| 84305 |
|
164 |
144 |
$2K |
| 82150 |
|
782 |
634 |
$2K |
| 99454 |
|
16 |
16 |
$2K |
| 82024 |
|
69 |
64 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
28 |
28 |
$2K |
| 36620 |
|
80 |
52 |
$2K |
| 76706 |
|
15 |
12 |
$2K |
| 91321 |
|
744 |
621 |
$2K |
| 92588 |
|
17 |
12 |
$1K |
| J1790 |
Injection, droperidol, up to 5 mg |
2,454 |
1,890 |
$1K |
| 92556 |
|
15 |
14 |
$1K |
| 85014 |
|
1,009 |
754 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,310 |
895 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,616 |
2,479 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
19,656 |
16,043 |
$1K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,608 |
1,069 |
$1K |
| 82232 |
|
141 |
111 |
$1K |
| 00142 |
|
1,869 |
1,347 |
$1K |
| 85384 |
|
275 |
209 |
$1K |
| 76825 |
|
45 |
37 |
$1K |
| 80175 |
|
170 |
145 |
$1K |
| 85613 |
|
517 |
217 |
$1K |
| D1110 |
Prophylaxis - adult |
13 |
13 |
$1K |
| 82140 |
|
357 |
226 |
$1K |
| 86663 |
|
130 |
107 |
$1K |
| Q2039 |
Influenza virus vaccine, not otherwise specified |
1,458 |
1,276 |
$1K |
| 82088 |
|
58 |
54 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
6,580 |
2,474 |
$1K |
| 76827 |
|
45 |
37 |
$1K |
| 84145 |
|
303 |
255 |
$1K |
| 84207 |
|
193 |
164 |
$1K |
| 84202 |
|
350 |
233 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
28,503 |
19,376 |
$1K |
| 92552 |
|
163 |
152 |
$1K |
| 83519 |
|
213 |
158 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
38,099 |
28,965 |
$1K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
4,248 |
3,752 |
$1K |
| 74220 |
|
19 |
17 |
$1K |
| 82270 |
|
501 |
414 |
$1K |
| 29125 |
|
1,154 |
967 |
$1K |
| 86618 |
|
183 |
157 |
$1K |
| 96137 |
|
552 |
504 |
$1K |
| 92652 |
|
19 |
12 |
$1K |
| 82103 |
|
132 |
118 |
$1K |
| 82390 |
|
222 |
178 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
11,924 |
7,966 |
$1K |
| 64636 |
|
24 |
13 |
$1K |
| 00320 |
|
141 |
93 |
$1K |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
369 |
283 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
4,753 |
2,075 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
45,139 |
31,279 |
$1K |
| 97016 |
|
28 |
14 |
$1K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
14 |
14 |
$988.81 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
1,186 |
321 |
$968.91 |
| 82085 |
|
172 |
141 |
$966.59 |
| 83498 |
|
250 |
207 |
$961.91 |
| 86480 |
|
34 |
32 |
$927.08 |
| 80353 |
|
67 |
41 |
$922.05 |
| 87625 |
|
308 |
263 |
$919.58 |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
60 |
45 |
$902.64 |
| 84075 |
|
409 |
322 |
$896.47 |
| 00300 |
|
422 |
318 |
$890.35 |
| 0073A |
|
61 |
21 |
$883.14 |
| 00140 |
|
70 |
52 |
$877.19 |
| 86664 |
|
130 |
107 |
$874.99 |
| 82164 |
|
94 |
83 |
$862.66 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
13 |
12 |
$842.20 |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,154 |
275 |
$841.01 |
| 76818 |
|
18 |
15 |
$829.24 |
| 76942 |
|
1,713 |
1,236 |
$803.58 |
| 98927 |
|
13 |
12 |
$800.90 |
| 88173 |
|
770 |
506 |
$797.58 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
372 |
209 |
$790.83 |
| 96161 |
|
16 |
16 |
$779.03 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,213 |
1,024 |
$776.00 |
| 88184 |
|
26 |
19 |
$761.32 |
| 82397 |
|
125 |
107 |
$745.66 |
| 82375 |
|
398 |
290 |
$743.48 |
| 00812 |
|
819 |
700 |
$736.17 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
4,503 |
1,986 |
$721.59 |
| 87102 |
|
83 |
54 |
$717.43 |
| 88185 |
|
49 |
18 |
$709.82 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
44,711 |
31,720 |
$683.44 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,919 |
822 |
$665.66 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
781 |
690 |
$657.00 |
| 72157 |
|
16 |
13 |
$647.14 |
| J7510 |
Prednisolone oral, per 5 mg |
493 |
443 |
$611.59 |
| 51702 |
|
404 |
319 |
$608.96 |
| Q4010 |
Cast supplies, short arm cast, adult (11 years +), fiberglass |
406 |
329 |
$605.96 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
2,037 |
1,755 |
$593.63 |
| 84244 |
|
54 |
52 |
$587.49 |
| 80179 |
|
564 |
412 |
$574.67 |
| J7050 |
Infusion, normal saline solution, 250 cc |
7,496 |
4,191 |
$565.03 |
| 86902 |
|
109 |
40 |
$564.73 |
| 83014 |
|
50 |
44 |
$559.59 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
7,510 |
4,399 |
$540.97 |
| 82668 |
|
65 |
53 |
$518.64 |
| 80074 |
|
47 |
39 |
$495.59 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
85 |
55 |
$494.19 |
| 83050 |
|
398 |
290 |
$470.75 |
| 86677 |
|
31 |
31 |
$463.83 |
| 84520 |
|
113 |
92 |
$463.38 |
| G0009 |
Administration of pneumococcal vaccine |
1,536 |
1,249 |
$461.86 |
| 64491 |
|
54 |
40 |
$453.43 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
1,833 |
730 |
$442.35 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
365 |
353 |
$427.55 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,850 |
2,145 |
$419.12 |
| 96409 |
|
79 |
54 |
$409.74 |
| 85651 |
|
595 |
473 |
$403.42 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
7,132 |
4,841 |
$398.73 |
| 72020 |
|
18 |
16 |
$393.39 |
| 86335 |
|
20 |
19 |
$383.12 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
4,622 |
2,897 |
$378.93 |
| J0184 |
Injection, amisulpride, 1 mg |
344 |
311 |
$377.51 |
| A4614 |
Peak expiratory flow rate meter, hand held |
431 |
322 |
$377.00 |
| 84300 |
|
142 |
108 |
$372.80 |
| 90660 |
|
39 |
39 |
$359.72 |
| 87075 |
|
379 |
210 |
$358.44 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,505 |
1,454 |
$350.43 |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
57 |
40 |
$349.27 |
| 81240 |
|
18 |
13 |
$346.90 |
| 86146 |
|
68 |
28 |
$345.77 |
| 86317 |
|
34 |
13 |
$341.87 |
| 80299 |
|
26 |
24 |
$336.83 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
724 |
477 |
$334.73 |
| 80202 |
|
40 |
26 |
$333.67 |
| J3360 |
Injection, diazepam, up to 5 mg |
491 |
199 |
$309.34 |
| 84590 |
|
49 |
39 |
$303.29 |
| 85007 |
|
508 |
367 |
$291.72 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,461 |
2,845 |
$289.88 |
| 80156 |
|
76 |
67 |
$286.08 |
| 00790 |
|
323 |
233 |
$278.39 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,103 |
827 |
$276.29 |
| 46600 |
|
223 |
211 |
$273.54 |
| 91319 |
|
262 |
215 |
$273.25 |
| 89051 |
|
454 |
296 |
$266.62 |
| 93284 |
|
18 |
14 |
$266.31 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
651 |
537 |
$263.53 |
| 83835 |
|
16 |
13 |
$256.89 |
| 73100 |
|
48 |
24 |
$256.28 |
| 87101 |
|
70 |
66 |
$252.40 |
| C1760 |
Closure device, vascular (implantable/insertable) |
235 |
166 |
$252.12 |
| 29130 |
|
412 |
355 |
$251.02 |
| 86777 |
|
20 |
12 |
$250.74 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,022 |
591 |
$247.99 |
| 88302 |
|
211 |
157 |
$235.47 |
| 95874 |
|
36 |
33 |
$231.99 |
| 80183 |
|
19 |
13 |
$215.17 |
| 69200 |
|
63 |
57 |
$213.83 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
109 |
94 |
$210.28 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
26,121 |
12,208 |
$208.39 |
| 0144A |
|
22 |
18 |
$208.26 |
| 99368 |
|
137 |
108 |
$205.00 |
| 88312 |
|
130 |
95 |
$204.80 |
| 88313 |
|
133 |
76 |
$204.53 |
| 87116 |
|
48 |
25 |
$203.95 |
| 87106 |
|
20 |
12 |
$201.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
607 |
476 |
$181.40 |
| 80185 |
|
36 |
16 |
$176.22 |
| 12031 |
|
13 |
12 |
$175.32 |
| 81241 |
|
18 |
13 |
$173.40 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
33 |
25 |
$170.48 |
| G0268 |
Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing |
163 |
155 |
$165.89 |
| 90649 |
|
16 |
12 |
$165.70 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,359 |
693 |
$164.47 |
| 86880 |
|
39 |
27 |
$162.10 |
| G0010 |
Administration of hepatitis b vaccine |
465 |
368 |
$160.89 |
| J1940 |
Injection, furosemide, up to 20 mg |
1,347 |
682 |
$156.86 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
224 |
99 |
$141.59 |
| 90473 |
|
255 |
204 |
$138.38 |
| 91300 |
|
14,213 |
13,271 |
$136.31 |
| A6213 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
717 |
486 |
$135.96 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
9,149 |
3,511 |
$129.25 |
| 82747 |
|
126 |
119 |
$122.75 |
| 98967 |
|
74 |
68 |
$119.80 |
| 90653 |
|
27 |
22 |
$118.29 |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
67 |
50 |
$116.61 |
| 80051 |
|
89 |
53 |
$114.58 |
| 36600 |
|
36 |
26 |
$114.58 |
| J2060 |
Injection, lorazepam, 2 mg |
884 |
619 |
$107.83 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
690 |
632 |
$105.71 |
| 29505 |
|
302 |
243 |
$105.64 |
| 95909 |
|
32 |
25 |
$103.86 |
| 80047 |
|
74 |
68 |
$101.56 |
| 77417 |
|
120 |
51 |
$93.54 |
| J1836 |
Injection, metronidazole, 10 mg |
522 |
252 |
$88.76 |
| J9190 |
Injection, fluorouracil, 500 mg |
498 |
127 |
$80.60 |
| 87184 |
|
21 |
18 |
$80.18 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
5,062 |
3,239 |
$79.89 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
115 |
93 |
$79.54 |
| 94799 |
|
157 |
129 |
$79.20 |
| 96411 |
|
734 |
367 |
$77.34 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
131 |
82 |
$73.97 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,164 |
2,006 |
$71.31 |
| Q4012 |
Cast supplies, short arm cast, pediatric (0-10 years), fiberglass |
110 |
89 |
$67.56 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
165 |
109 |
$67.13 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
31 |
13 |
$61.74 |
| J2785 |
Injection, regadenoson, 0.1 mg |
994 |
808 |
$61.15 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
2,078 |
1,740 |
$60.89 |
| J2359 |
Injection, olanzapine, 0.5 mg |
16 |
12 |
$59.47 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
7,790 |
6,039 |
$56.77 |
| 83930 |
|
19 |
12 |
$54.86 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
59 |
42 |
$54.76 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
2,782 |
2,029 |
$54.25 |
| 87350 |
|
13 |
12 |
$53.22 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
252 |
178 |
$52.57 |
| 96139 |
|
128 |
113 |
$49.74 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,495 |
630 |
$49.34 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
2,623 |
1,955 |
$47.61 |
| Q4038 |
Cast supplies, short leg cast, adult (11 years +), fiberglass |
55 |
44 |
$46.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
661 |
226 |
$45.81 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
436 |
211 |
$44.58 |
| 91318 |
|
15 |
14 |
$43.75 |
| 73010 |
|
12 |
12 |
$41.63 |
| 91301 |
|
4,300 |
4,108 |
$40.06 |
| 98968 |
|
14 |
14 |
$39.54 |
| J1630 |
Injection, haloperidol, up to 5 mg |
243 |
161 |
$39.42 |
| 88311 |
|
70 |
49 |
$37.14 |
| 86707 |
|
13 |
12 |
$36.34 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
859 |
636 |
$34.94 |
| 51797 |
|
413 |
374 |
$33.23 |
| 84134 |
|
12 |
12 |
$29.11 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
831 |
584 |
$28.24 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
198 |
111 |
$25.88 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
15 |
15 |
$25.25 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
573 |
349 |
$24.59 |
| 91312 |
|
3,885 |
2,456 |
$24.40 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
73 |
42 |
$22.85 |
| 91307 |
|
3,048 |
2,226 |
$22.09 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
384 |
364 |
$20.84 |
| D0272 |
Bitewings - two radiographic images |
132 |
100 |
$18.78 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
381 |
326 |
$18.28 |
| A4620 |
Variable concentration mask |
2,579 |
2,097 |
$16.11 |
| 89060 |
|
14 |
12 |
$14.62 |
| J0456 |
Injection, azithromycin, 500 mg |
98 |
54 |
$13.33 |
| 91305 |
|
2,016 |
959 |
$10.09 |
| 83935 |
|
12 |
12 |
$9.74 |
| 90611 |
|
185 |
171 |
$8.53 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
14 |
13 |
$7.17 |
| A6219 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
1,271 |
882 |
$7.07 |
| 91311 |
|
841 |
556 |
$6.24 |
| J2305 |
Injection, nitroglycerin, 5 mg |
132 |
95 |
$5.92 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,133 |
626 |
$4.62 |
| 91315 |
|
435 |
326 |
$3.72 |
| C1769 |
Guide wire |
1,761 |
1,309 |
$3.16 |
| 92025 |
|
27 |
27 |
$2.65 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
2,087 |
1,539 |
$2.33 |
| 92060 |
|
127 |
127 |
$2.29 |
| 91313 |
|
300 |
187 |
$1.91 |
| 91316 |
|
130 |
112 |
$1.24 |
| 91303 |
|
81 |
77 |
$0.76 |
| 91314 |
|
35 |
30 |
$0.06 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
879 |
761 |
$0.04 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
815 |
633 |
$0.03 |
| 00813 |
|
736 |
579 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
613 |
425 |
$0.00 |
| 01214 |
|
108 |
76 |
$0.00 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
43 |
33 |
$0.00 |
| C1819 |
Surgical tissue localization and excision device (implantable) |
386 |
279 |
$0.00 |
| 00952 |
|
245 |
186 |
$0.00 |
| 77001 |
|
278 |
220 |
$0.00 |
| 00126 |
|
14 |
14 |
$0.00 |
| 01480 |
|
492 |
343 |
$0.00 |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
42 |
28 |
$0.00 |
| 36410 |
|
28 |
27 |
$0.00 |
| 96377 |
|
69 |
39 |
$0.00 |
| 29540 |
|
161 |
142 |
$0.00 |
| 01400 |
|
46 |
26 |
$0.00 |
| 00160 |
|
12 |
12 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
61 |
49 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
25 |
25 |
$0.00 |
| D0240 |
|
62 |
44 |
$0.00 |
| C1781 |
Mesh (implantable) |
111 |
67 |
$0.00 |
| 00190 |
|
16 |
12 |
$0.00 |
| 86812 |
|
13 |
12 |
$0.00 |
| 64484 |
|
12 |
12 |
$0.00 |
| C1729 |
Catheter, drainage |
462 |
323 |
$0.00 |
| 77387 |
|
93 |
13 |
$0.00 |
| 29530 |
|
386 |
308 |
$0.00 |
| 00910 |
|
236 |
184 |
$0.00 |
| 01810 |
|
770 |
609 |
$0.00 |
| 00732 |
|
16 |
12 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
288 |
238 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
653 |
463 |
$0.00 |
| 01830 |
|
365 |
279 |
$0.00 |
| 01402 |
|
224 |
137 |
$0.00 |
| 86703 |
|
106 |
97 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,407 |
1,067 |
$0.00 |
| C1758 |
Catheter, ureteral |
86 |
70 |
$0.00 |
| 96381 |
|
15 |
15 |
$0.00 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
167 |
129 |
$0.00 |
| 99001 |
|
12 |
12 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
33 |
30 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
56 |
48 |
$0.00 |
| 76376 |
|
99 |
95 |
$0.00 |
| 92100 |
|
42 |
30 |
$0.00 |
| H1002 |
Prenatal care, at risk enhanced service; care coordination |
1,279 |
1,241 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
80 |
75 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
18 |
12 |
$0.00 |
| 75565 |
|
16 |
12 |
$0.00 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
12 |
12 |
$0.00 |
| 01844 |
|
19 |
15 |
$0.00 |
| 00920 |
|
39 |
26 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
17 |
12 |
$0.00 |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
14 |
12 |
$0.00 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
46 |
14 |
$0.00 |
| 00402 |
|
13 |
12 |
$0.00 |
| 0141A |
|
12 |
12 |
$0.00 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
16 |
14 |
$0.00 |
| 93321 |
|
31 |
26 |
$0.00 |
| 51703 |
|
12 |
12 |
$0.00 |